Member Info for lselsf

Why would 1250 have been unreal to begin with? Because it is a drop from the level at which you entered? And this because a big, known company's SP is not supposed to fall? I really can't follow the reasoning on most of these posts, has there been any research or analysis before buying (or selling)? Understanding what's in the pipeline, licenses, agreements, disputes, rivals, management. Please, please do some due diligence before buying shares. If you are posting here having bought shares in GSK and then don't know who Emma is then you may as well just play random gambling or just put into an index tracker.

Curious why you would invest given the drop is a continuing trend due to poor management and not some temporary day event. Emma has been the wrong choice, the sooner GSK admit it the better otherwise this will continue trending much further. GSK, in its current state, does not merit a P/E of 40.

I halved my stake in ABDP today, partly to offset my losses against CLLN, but mostly because I believe this is now overvalued following recent uptick. This is a good company and a good share to own but SP above 800, P/E in 40-50 range is too much.

Changed Thursday on AJ Bell platform, Morningstar, etc.

Low float exaggerates the movements, even trade history not just SP updates are limited. This is a small cap undergoing major change and there will still be uncertainty for most until the sale goes through hence gyrations are to be expected. Don't look for too much logic in explaining the SP in the short term. I'm disappointed it went down as much as 8% earlier today, I had topped up Tuesday after the RNS!

Increased Shareholder Support for Disposal proposal of Video Business updated to be just under 60% today, so it will most likely go thorough without problem. Bizarrely, SP down 6% today after 4% increase yesterday.

This is a good deal. The cash injection is secondary, it allows full focus on ThruVis being increasingly adopted by major users such as G4S, TSA, etc. with the correct employee structure at all levels. As mentioned, due to low market cap and float share price may not behave as expected day to day, DGB is not ideal for day trading, it is a good long term investment.

No. There is no RNS.

The people screening in real time is the niche product. DGB's technology is miles ahead of the game. By focusing all efforts, including Business/Marketing not just R&D, on this it can easily become mainstream. TSA and other governments using is one thing but once it penetrates into commercial application, whether perimeter security for a building or internal identification in confined places. This is potentially a share/company that could easily be x10 within 5 years.